Enhancing antitumor by immunization with fusion of dendritic cells and engineered tumor cells

scientific article published on January 2002

Enhancing antitumor by immunization with fusion of dendritic cells and engineered tumor cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF02904773
P698PubMed publication ID12658768

P2093author name stringHong Yang
Weidong Zhang
Hongtao Zeng
P2860cites workDendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunityQ36380749
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivoQ37599151
The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryosQ40642168
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignanciesQ40751781
Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transferQ40865015
Origin, maturation and antigen presenting function of dendritic cells.Q40906220
Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.Q42814193
Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.Q45868776
IL-12 gene therapy for cancer: in synergy with other immunotherapiesQ45876151
Fusion induces tumour rejectionQ59076228
Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cellsQ64381308
Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10Q71029697
Augmentation of antitumor immunity by genetically engineered fibroblast cells to express both B7.1 and interleukin-7Q73795133
P433issue1
P921main subjectdendritic cellQ506253
P304page(s)1-4
P577publication date2002-01-01
P1433published inJournal of Huazhong University of Science and Technology. Medical SciencesQ15711092
P1476titleEnhancing antitumor by immunization with fusion of dendritic cells and engineered tumor cells
P478volume22

Reverse relations

cites work (P2860)
Q34898366Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.
Q37806963Regulation of tumor immunity by tumor/dendritic cell fusions
Q38617733The impact of dendritic cell-tumor fusion cells on cancer vaccines - past progress and future strategies

Search more.